Bold Capital Partners, co-founded by Peter Diamandis, is a venture capital firm that focuses on investing in technology companies. The firm typically participates in various stages of funding, including Seed, Series A, Series B, and beyond. Their investment portfolio spans multiple sectors within the tech industry, showcasing a diverse range of innovative companies.
Notable portfolio companies include AliveCor, Viome, Colossal Biosciences, and Insilico Medicine. Bold Capital Partners is known for its strategic investment philosophy and commitment to supporting groundbreaking technologies. The firm offers unique value-add services to its portfolio companies, leveraging the extensive experience and networks of its key partners to drive growth and innovation.
Bold Capital Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments80
Current Portfolio Count40
Total Portfolio Exits0
Top Investment Stages
Series A28 (38.4%)
Series B18 (24.7%)
Seed17 (23.3%)
Series C5 (6.8%)
Series Unknown5 (6.8%)
Stage Mix
Series A 38%Series B 25%Seed 23%Series C 7%Series Unknown 7%
Concentration shown as share of disclosed investments by stage.
Bold Capital Partners - Classification
- Also Known As
- Bold Capital Partners, LP
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end